Setmelanotide Phase 2 Treatment Trial in Participants With Rare Genetic Disorders of Obesity

Clinical trial NCT03013543 · COMPLETED

Trial details

NCT number: NCT03013543
Sponsor: Rhythm Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Genetic Obesity Obesity Obesity Due to Melanocortin 4 Receptor Deficiency

Start date: 2017-02-10
Primary completion: 2022-03-01
Enrollment: 213

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.